These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 8352517

  • 1. [Efficacy and tolerance of imipenem/cilastatin in the adjuvant treatment of surgery for peritonitis in patients over the age of 70 years].
    Janvier G, Carles J.
    Ann Chir; 1993; 47(4):370-5. PubMed ID: 8352517
    [Abstract] [Full Text] [Related]

  • 2. [Study of the efficacy and tolerance of imipenem-cilastatin used as monotherapy for the adjuvant treatment to surgery of peritonitis. Results of a French multicenter study including 257 patients].
    Midy D, Pometan JP, Baste JC, Pajadon V.
    J Chir (Paris); 1992; 129(6-7):303-8. PubMed ID: 1474112
    [Abstract] [Full Text] [Related]

  • 3. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
    Bartoloni A, Strohmeyer M, Corti G, Buonomini MI, Franchino L, Romanelli G, Moretti AM, De Vizzi GB, Petraglia A, Mancini P, Atzeni R, Fogliani V, Giura R, Paradisi F.
    Drugs Exp Clin Res; 1999; 25(6):243-52. PubMed ID: 10713862
    [Abstract] [Full Text] [Related]

  • 4. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
    Cakmakci M, Stern A, Schilling J, Christen D, Roggo A, Geroulanos S.
    Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495
    [Abstract] [Full Text] [Related]

  • 5. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
    Kuo BI, Fung CP, Liu CY.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445
    [Abstract] [Full Text] [Related]

  • 6. [Study of the intraperitoneal penetration of imipenem/cilastatin in acute peritonitis with perforation].
    Pezé P, Mounier M, Cevallos R, Denis F.
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):504-7. PubMed ID: 2385446
    [Abstract] [Full Text] [Related]

  • 7. A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections.
    Hou F, Li J, Wu G, Zheng B, Chen Y, Gu J, Wang H, Huo L, Xue X, Jia C, Yin Y, Tian X, Ren S.
    Chin Med J (Engl); 2002 Dec; 115(12):1849-54. PubMed ID: 12622937
    [Abstract] [Full Text] [Related]

  • 8. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Garbino J, Villiger P, Caviezel A, Matulionyte R, Uckay I, Morel P, Lew D.
    Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
    [Abstract] [Full Text] [Related]

  • 9. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Cherif H, Björkholm M, Engervall P, Johansson P, Ljungman P, Hast R, Kalin M.
    Scand J Infect Dis; 2004 Jun; 36(8):593-600. PubMed ID: 15370671
    [Abstract] [Full Text] [Related]

  • 10. A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections.
    Angerås MH, Darle N, Hamnström K, Ekelund M, Engström L, Takala J, Viste A, Holme JB.
    Scand J Infect Dis; 1996 Jun; 28(5):513-8. PubMed ID: 8953684
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of two comparative antibiotic regimens in the treatment of serious intra-abdominal infections: results of a multicenter study.
    Eckhauser FE, Knol JA, Raper SE, Mulholland MW, Helzerman P.
    Clin Ther; 1992 Jun; 14(1):97-109. PubMed ID: 1576632
    [Abstract] [Full Text] [Related]

  • 12. Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections.
    Niinikoski J, Havia T, Alhava E, Pääkkönen M, Miettinen P, Kivilaakso E, Haapiainen R, Matikainen M, Laitinen S.
    Surg Gynecol Obstet; 1993 Mar; 176(3):255-61. PubMed ID: 8382381
    [Abstract] [Full Text] [Related]

  • 13. Clinical evaluation of imipenem/cilastatin in the therapy of severe infections in high-risk patients.
    Cristiano P.
    Drugs Exp Clin Res; 1989 Mar; 15(1):17-20. PubMed ID: 2743870
    [Abstract] [Full Text] [Related]

  • 14. [Contribution of imipenem/cilastatin in the treatment of peritonitis: a comparative economic analysis in the case of France].
    Levy E, Levy P.
    J Chir (Paris); 1993 Apr; 130(4):200-9. PubMed ID: 8345014
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
    Miller JA, Butler T, Beveridge RA, Kales AN, Binder RA, Smith LJ, Ueno WM, Milkovich G, Goldwater S, Marion A.
    Clin Ther; 1993 Apr; 15(3):486-99. PubMed ID: 8364941
    [Abstract] [Full Text] [Related]

  • 16. Imipenem versus netilmicin and vancomycin in the treatment of CAPD peritonitis.
    Merchant MR, Anwar N, Were A, Uttley L, Tooth JA, Gokal R.
    Adv Perit Dial; 1992 Apr; 8():234-7. PubMed ID: 1361795
    [Abstract] [Full Text] [Related]

  • 17. Impact an anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections.
    Wilson SE, Faulkner K.
    Am Surg; 1998 May; 64(5):402-7. PubMed ID: 9585772
    [Abstract] [Full Text] [Related]

  • 18. Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections.
    Zanetti G, Harbarth SJ, Trampuz A, Ganeo M, Mosimann F, Chautemps R, Morel P, Lew D, Zimmerli W, Lange J, Glauser M.
    Int J Antimicrob Agents; 1999 Feb; 11(2):107-13. PubMed ID: 10221413
    [Abstract] [Full Text] [Related]

  • 19. Neurological complication during imipenem/cilastatin therapy in uraemic patients.
    Campise M.
    Nephrol Dial Transplant; 1998 Jul; 13(7):1895-6. PubMed ID: 9681765
    [No Abstract] [Full Text] [Related]

  • 20. Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery.
    Kanellakopoulou K, Giamarellou H, Papadothomakos P, Tsipras H, Chloroyiannis J, Theakou R, Sfikakis P.
    Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):449-53. PubMed ID: 8359165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.